NCT06396403View on ClinicalTrials.gov

The Role of Red Cell Characteristics, Angiogenesis, Viscosity and Oxygenation in the Pathophysiology of Sickle Cell Related Retinopathy

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

June 13, 2023

Primary Completion Date

June 17, 2024

Study Completion Date

June 17, 2024

Conditions
Sickle Cell RetinopathySickle Cell DiseaseSickle Cell SC DiseaseSickle Cell-SS Disease
Interventions
OTHER

Collection of venous blood samples

collection includes 1 EDTA tube and 1 Sarstedt S-Monovette tube of 5 mL

Trial Locations (1)

1105AZ

Amsterdam UMC, Amsterdam

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT06396403 - The Role of Red Cell Characteristics, Angiogenesis, Viscosity and Oxygenation in the Pathophysiology of Sickle Cell Related Retinopathy | Biotech Hunter | Biotech Hunter